# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-18-002770
Filing Date
2018-04-13
Accepted
2018-04-13 06:09:08
Documents
9
Period of Report
2018-06-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | a2235295zpre14a.htm | PRE 14A | 949678
2 | G429299.JPG | g429299.jpg | GRAPHIC | 23328
3 | G650180.JPG | g650180.jpg | GRAPHIC | 8714
4 | G245976.JPG | g245976.jpg | GRAPHIC | 8525
5 | G677153.JPG | g677153.jpg | GRAPHIC | 32369
6 | G144310.JPG | g144310.jpg | GRAPHIC | 31749
7 | G28372BGI001.GIF | g28372bgi001.gif | GRAPHIC | 121347
8 | G28372BII001.GIF | g28372bii001.gif | GRAPHIC | 155763
9 | G28372BKI001.GIF | g28372bki001.gif | GRAPHIC | 200597
| Complete submission text file | 0001047469-18-002770.txt |  | 1753551

Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33497 | Film No.: 18753098
SIC: 2834 Pharmaceutical Preparations